PARP-1 inhibitor MK-4827 in combination with radiation as a treatment strategy for metastatic neuroblastoma.
S. Bhargava
No relevant relationships to disclose
S. Mueller
No relevant relationships to disclose
L. Wehmeijer
No relevant relationships to disclose
X. Yang
No relevant relationships to disclose
A. Gragg
No relevant relationships to disclose
K. K. Matthay
No relevant relationships to disclose
W. A. Weiss
No relevant relationships to disclose
D. A. Haas-Kogan
No relevant relationships to disclose